Replies to post #9885 on Long Term Investment, Biotech & High Yield Dividen

[califax]

Apricus Biosciences Announces FDA Clearance for Its Second OTC Anti-Itch Drug (Hydrocortisone-D(TM)) Containing NexACT(R) Technology

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=66447622